129 related articles for article (PubMed ID: 17499997)
1. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum.
Liu J; Shimizu K; Konishi F; Kumamoto S; Kondo R
Bioorg Med Chem; 2007 Jul; 15(14):4966-72. PubMed ID: 17499997
[TBL] [Abstract][Full Text] [Related]
2. Anti-androgen effects of extracts and compounds from Ganoderma lucidum.
Liu J; Tamura S; Kurashiki K; Shimizu K; Noda K; Konishi F; Kumamoto S; Kondo R
Chem Biodivers; 2009 Feb; 6(2):231-43. PubMed ID: 19235153
[TBL] [Abstract][Full Text] [Related]
3. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
Liu J; Shiono J; Shimizu K; Kukita A; Kukita T; Kondo R
Bioorg Med Chem Lett; 2009 Apr; 19(8):2154-7. PubMed ID: 19289282
[TBL] [Abstract][Full Text] [Related]
4. Anti-androgenic activities of Ganoderma lucidum.
Fujita R; Liu J; Shimizu K; Konishi F; Noda K; Kumamoto S; Ueda C; Tajiri H; Kaneko S; Suimi Y; Kondo R
J Ethnopharmacol; 2005 Oct; 102(1):107-12. PubMed ID: 16029938
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum.
Liu J; Kurashiki K; Shimizu K; Kondo R
Bioorg Med Chem; 2006 Dec; 14(24):8654-60. PubMed ID: 16962782
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells.
Zaidman BZ; Wasser SP; Nevo E; Mahajna J
Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330
[TBL] [Abstract][Full Text] [Related]
7. Anti-androgenic activity of fatty acids.
Liu J; Shimizu K; Kondo R
Chem Biodivers; 2009 Apr; 6(4):503-12. PubMed ID: 19353546
[TBL] [Abstract][Full Text] [Related]
8. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
9. Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Phytomedicine; 2011 Sep; 18(12):1053-5. PubMed ID: 21596546
[TBL] [Abstract][Full Text] [Related]
10. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
11. Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells.
Lee HH; Ho CT; Lin JK
Carcinogenesis; 2004 Jul; 25(7):1109-18. PubMed ID: 14963012
[TBL] [Abstract][Full Text] [Related]
12. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer.
Ho LL; Kench JG; Handelsman DJ; Scheffer GL; Stricker PD; Grygiel JG; Sutherland RL; Henshall SM; Allen JD; Horvath LG
Prostate; 2008 Sep; 68(13):1421-9. PubMed ID: 18615486
[TBL] [Abstract][Full Text] [Related]
13. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM; Frazier MC; Harris WB
Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
[TBL] [Abstract][Full Text] [Related]
14. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Liu CM; Lo YC; Tai MH; Wu BN; Wu WJ; Chou YH; Chai CY; Huang CH; Chen IJ
Prostate; 2009 May; 69(6):610-23. PubMed ID: 19143029
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
16. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
Paliouras M; Diamandis EP
Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
[TBL] [Abstract][Full Text] [Related]
17. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators.
Yu S; Wang MW; Yao X; Chan FL
Biochem Biophys Res Commun; 2009 May; 382(4):756-61. PubMed ID: 19324023
[TBL] [Abstract][Full Text] [Related]
19. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Fitoterapia; 2010 Dec; 81(8):1033-6. PubMed ID: 20603199
[TBL] [Abstract][Full Text] [Related]
20. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells.
Lee I; Seo J; Kim J; Kim H; Youn U; Lee J; Jung H; Na M; Hattori M; Min B; Bae K
J Nat Prod; 2010 Feb; 73(2):172-6. PubMed ID: 20039640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
